128
Views
0
CrossRef citations to date
0
Altmetric
Review

Pneumatic dilation for esophageal achalasia: patient selection and perspectives

ORCID Icon, , , , &
Received 04 Dec 2021, Accepted 21 Jan 2022, Published online: 03 Feb 2022

Bibliography

  • Mearin F, Mourelle M, Guarner F, et al. Patients with achalasia lack nitric oxide synthase in the gastro-oesophageal junction. Eur J Clin Invest. 1993;23(11):724–728.
  • Park W, Vaezi MF. Etiology and pathogenesis of achalasia: the current understanding. Am J Gastroenterol. 2005;100(6):1404–1414.
  • Sadowski DC, Ackah F, Jiang B, et al. Achalasia: incidence, prevalence and survival. A population-based study. Neurogastroenterol Motil. 2010;22(9):e256-261–e261.
  • Katzka DA, Castell DO. Review article: an analysis of the efficacy, perforation rates and methods used in pneumatic dilation for achalasia. Aliment Pharmacol Ther. 2011;34(8):832–839.
  • Schlottmann F, Luckett DJ, Fine J, et al. Laparoscopic Heller myotomy versus peroral endoscopic myotomy (POEM) for achalasia: a systematic review and meta-analysis. Ann Surg. 2018;267(3):451–460.
  • Levine ML, Dorf BS, Moskowitz G, et al. Pneumatic dilatation in achalasia under endoscopic guidance: correlation pre- and postdilatation by radionuclide scintiscan. Am J Gastroenterol. 1987;82(4):311–314.
  • Stark GA, Castell DO, Richter JE, et al. Prospective randomized comparison of Brown-McHardy and microvasive balloon dilators in treatment of achalasia. Am J Gastroenterol. 1990;85(10):1322–1326.
  • Muehldorfer SM, Hahn EG, Ell C. High- and low-compliance balloon dilators in patients with achalasia: a randomized prospective comparative trial. Gastrointest Endosc. 1996;44(4):398–403.
  • Kahrilas PJ, Kishk SM, Helm JF, et al. Comparison of pseudoachalasia and achalasia. Am J Med. 1987;82(3):439–446.
  • Blonski W, Kumar A, Feldman J, et al. Timed barium swallow: diagnostic role and predictive value in untreated achalasia, esophagogastric junction outflow obstruction, and non-achalasia dysphagia. Am J Gastroenterol. 2018;113(2):196–203.
  • Pandolfino JE, Kwiatek MA, Nealis T, et al. Achalasia: a new clinically relevant classification by high-resolution manometry. Gastroenterology. 2008;135(5):1526–1533.
  • Kahrilas PJ, International High Resolution Manometry Working Group, Bredenoord AJ, Fox M, et al. The Chicago classification of esophageal motility disorders, v3.0. Neurogastroenterol Motil. 2015;27(2):160–174.
  • Riley SA, Attwood SEA. Guidelines on the use of oesophageal dilatation in clinical practice. Gut. 2004;53 (Suppl 1):i1–i6.
  • Eckardt VF, Gockel I, Bernhard G. Pneumatic dilation for achalasia: late results of a prospective follow up investigation. Gut. 2004;53(5):629–633.
  • Oude Nijhuis RAB, Prins LI, Mostafavi N, et al. Factors associated with achalasia treatment outcomes: systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2020;18(7):1442–1453.
  • Farhoomand K, Connor JT, Richter JE, et al. Predictors of outcome of pneumatic dilation in achalasia. Clin Gastroenterol Hepatol. 2004;2(5):389–394.
  • Pratap N, Kalapala R, Darisetty S, et al. Achalasia cardia subtyping by high-resolution manometry predicts the therapeutic outcome of pneumatic balloon dilatation. J Neurogastroenterol Motil. 2011;17(1):48–53.
  • Lee H, Korean Achalasia Study Team (KAST), Chung H, Lee TH, et al. Therapeutic outcome of achalasia based on high-resolution manometry: a Korean multicenter study. Am J Ther. 2019;26(4):e452–e461.
  • Rohof WO, Salvador R, Annese V, et al. Outcomes of treatment for achalasia depend on manometric subtype. Gastroenterology. 2013;144(4):718–725. quiz e13–14.
  • Ou YH, Nie XM, Li LF, et al. High-resolution manometric subtypes as a predictive factor for the treatment of achalasia: a meta-analysis and systematic review. J Dig Dis. 2016;17(4):222–235.
  • Veitch AM, Radaelli F, Alikhan R, et al. Endoscopy in patients on antiplatelet or anticoagulant therapy: British Society of Gastroenterology (BSG) and European Society of Gastrointestinal Endoscopy (ESGE) guideline update. Endoscopy. 2021;53(9):947–969.
  • Boeckxstaens GE, Zaninotto G, Richter JE. Achalasia. Lancet. 2014;383(9911):83–93.
  • Eckardt VF, Aignherr C, Bernhard G. Predictors of outcome in patients with achalasia treated by pneumatic dilation. Gastroenterology. 1992;103(6):1732–1738.
  • Hulselmans M, Vanuytsel T, Degreef T, et al. Long-term outcome of pneumatic dilation in the treatment of achalasia. Clin Gastroenterol Hepatol. 2010;8(1):30–35.
  • Vela MF, Richter JE, Khandwala F, et al. The long-term efficacy of pneumatic dilatation and Heller myotomy for the treatment of achalasia. Clin Gastroenterol Hepatol. 2006;4(5):580–587.
  • van Hoeij FB, Prins LI, Smout AJPM, et al. Efficacy and safety of pneumatic dilation in achalasia: a systematic review and meta-analysis. Neurogastroenterol Motil. 2019;31(7):e13548.
  • Vaezi MF, Pandolfino JE, Yadlapati RH, et al. ACG clinical guidelines: diagnosis and management of achalasia. Am J Gastroenterol. 2020;115(9):1393–1411.
  • Lynch KL, Pandolfino JE, Howden CW, et al. Major complications of pneumatic dilation and Heller myotomy for achalasia: single-center experience and systematic review of the literature. Am J Gastroenterol. 2012;107(12):1817–1825.
  • Eckardt VF, Kanzler G, Westermeier T. Complications and their impact after pneumatic dilation for achalasia: prospective long-term follow-up study. Gastrointest Endosc. 1997;45(5):349–353.
  • Zori AG, Kirtane TS, Gupte AR, et al. Utility of clinical suspicion and endoscopic re-examination for detection of esophagogastric perforation after pneumatic dilation for achalasia. Endoscopy. 2016;48(2):128–133.
  • Hunt DR, Wills VL, Weis B, et al. Management of esophageal perforation after pneumatic dilation for achalasia. J Gastrointest Surg. 2000;4(4):411–415.
  • Costamagna G, Marchese M. Management of esophageal perforation after therapeutic endoscopy. Gastroenterol Hepatol (N Y). 2010;6(6):391–392.
  • Sanaka MR, Raja S, Thota PN. Esophageal perforation after pneumatic dilation for achalasia: successful closure with an over-the-scope clip. J Clin Gastroenterol. 2016;50(3):267–268.
  • Vaezi MF, Baker ME, Achkar E, et al. Timed barium oesophagram: better predictor of long term success after pneumatic dilation in achalasia than symptom assessment. Gut. 2002;50(6):765–770.
  • van Hoeij FB, Smout AJPM, Bredenoord AJ. Esophageal stasis in achalasia patients without symptoms after treatment does not predict symptom recurrence. Neurogastroenterol Motil. 2017;29(8):e13059.
  • Khashab MA, Vela MF, Thosani N, et al. ASGE guideline on the management of achalasia. Gastrointest Endosc. 2020;91(2):213–227.e6.
  • Vaezi MF, Pandolfino JE, Vela MF. ACG clinical guideline: diagnosis and management of achalasia. Am J Gastroenterol. 2013;108(8):1238–1249. quiz 1250.
  • Zerbib F, Thétiot V, Richy F, et al. Repeated pneumatic dilations as long-term maintenance therapy for esophageal achalasia. Am J Gastroenterol. 2006;101(4):692–697.
  • Moonen A, Annese V, Belmans A, et al. Long-term results of the European achalasia trial: a multicentre randomised controlled trial comparing pneumatic dilation versus laparoscopic *heller myotomy. Gut. 2016;65(5):732–739.
  • Alderliesten J, Conchillo JM, Leeuwenburgh I, et al. Predictors for outcome of failure of balloon dilatation in patients with achalasia. Gut. 2011;60(1):10–16.
  • Smeets FGM, Masclee AAM, Keszthelyi D, et al. Esophagogastric junction distensibility in the management of achalasia patients: relation to treatment outcome. Neurogastroenterol Motil. 2015;27(10):1495–1503.
  • Fernandez-Ananin S, Fernández AF, Balagué C, et al. What to do when Heller's myotomy fails? Pneumatic dilatation, laparoscopic remyotomy or peroral endoscopic myotomy: a systematic review. J Minim Access Surg. 2018;14(3):177–184.
  • Saleh CMG, Ponds FAM, Schijven MP, et al. Efficacy of pneumodilation in achalasia after failed Heller myotomy. Neurogastroenterol Motil. 2016;28(11):1741–1746.
  • van Hoeij FB, Ponds FA, Werner Y, et al. Management of recurrent symptoms after per-oral endoscopic myotomy in achalasia. Gastrointest Endosc. 2018;87(1):95–101.
  • Ichkhanian Y, Assis D, Familiari P, et al. Management of patients after failed peroral endoscopic myotomy: a multicenter study. Endoscopy. 2021;53(10):1003–1010.
  • Khudyak V, Lysy J, Mankuta D. Achalasia in pregnancy. Obstet Gynecol Surv. 2006;61(3):207–211.
  • Rai RR, Shende A, Joshi A, et al. Rigiflex pneumatic dilation of achalasia without fluoroscopy: a novel office procedure. Gastrointest Endosc. 2005;62(3):427–431.
  • Khan AA, Shah SWH, Alam A, et al. Efficacy of rigiflex balloon dilatation in 12 children with achalasia: a 6-month prospective study showing weight gain and symptomatic improvement. Dis Esophagus. 2002;15(2):167–170.
  • Babu R, Grier D, Cusick E, et al. Pneumatic dilatation for childhood achalasia. Pediatr Surg Int. 2001;17(7):505–507.
  • Boyle JT, Cohen S, Watkins JB. Successful treatment of achalasia in childhood by pneumatic dilatation. J Pediatr. 1981;99(1):35–40.
  • Perisic VN, Scepanovic D, Radlovic N. Nonoperative treatment of achalasia. J Pediatr Gastroenterol Nutr. 1996;22(1):45–47.
  • Di Nardo G, Rossi P, Oliva S, et al. Pneumatic balloon dilation in pediatric achalasia: efficacy and factors predicting outcome at a single tertiary pediatric gastroenterology center. Gastrointest Endosc. 2012;76(5):927–932.
  • van Lennep M, van Wijk MP, Omari TIM, et al. Clinical management of pediatric achalasia. Expert Rev Gastroenterol Hepatol. 2018;12(4):391–404.
  • Smits M, van Lennep M, Vrijlandt R, et al. Pediatric achalasia in The Netherlands: incidence, clinical course, and quality of life. J Pediatr. 2016;169:110–115.e3.
  • Pastor AC, Mills J, Marcon MA, et al. A single center 26-year experience with treatment of esophageal achalasia: is there an optimal method? J Pediatr Surg. 2009;44(7):1349–1354.
  • Zagory JA, Golden JM, Demeter NE, et al. Heller myotomy is superior to balloon dilatation or botulinum injection in children with achalasia: a two-center review. J Laparoendosc Adv Surg Tech A. 2016;26(6):483–487.
  • Saliakellis E, Thapar N, Roebuck D, et al. Long-term outcomes of Heller’s myotomy and balloon dilatation in childhood achalasia. Eur J Pediatr. 2017;176(7):899–907.
  • Robertson CS, Fellows IW, Mayberry JF, et al. Choice of therapy for achalasia in relation to age. Digestion. 1988;40(4):244–250.
  • Bright T. Pneumatic balloon dilatation for achalasia—how and why I do it. Ann Esophagus. 2020;3(0):25–25.
  • Nair LA, Reynolds JC, Parkman HP, et al. Complications during pneumatic dilation for achalasia or diffuse esophageal spasm. Analysis of risk factors, early clinical characteristics, and outcome. Dig Dis Sci. 1993;38(10):1893–1904.
  • Schwartz HM, Cahow CE, Traube M. Outcome after perforation sustained during pneumatic dilatation for achalasia. Dig Dis Sci. 1993;38(8):1409–1413.
  • Metman E-H, Lagasse J-P, d'Alteroche L, et al. Risk factors for immediate complications after progressive pneumatic dilation for achalasia. Am J Gastroenterol. 1999;94(5):1179–1185.
  • Boeckxstaens GE, European Achalasia Trial Investigators, Annese V, Des Varannes SB, et al. Pneumatic dilation versus laparoscopic Heller's myotomy for idiopathic achalasia. N Engl J Med. 2011;364(19):1807–1816.
  • Coccia G, Bortolotti M, Michetti P, et al. Prospective clinical and manometric study comparing pneumatic dilatation and sublingual nifedipine in the treatment of oesophageal achalasia. Gut. 1991;32(6):604–606.
  • Vaezi MF, Richter JE. Current therapies for achalasia: comparison and efficacy. J Clin Gastroenterol. 1998;27(1):21–35.
  • Vaezi MF, Richter JE, Wilcox CM, et al. Botulinum toxin versus pneumatic dilatation in the treatment of achalasia: a randomised trial. Gut. 1999;44(2):231–239.
  • Leyden JE, Moss AC, MacMathuna P. Endoscopic pneumatic dilation versus botulinum toxin injection in the management of primary achalasia. Cochrane Database Syst Rev. 2014;(12)CD005046.
  • Ali A, Pellegrini CA. Laparoscopic myotomy: technique and efficacy in treating achalasia. Gastrointest Endosc Clin N Am. 2001;11(2):347–358. vii.
  • Chrystoja CC, Darling GE, Diamant NE, et al. Achalasia-specific quality of life after pneumatic dilation or laparoscopic Heller myotomy with partial fundoplication: a multicenter, randomized clinical trial. Am J Gastroenterol. 2016;111(11):1536–1545.
  • Cheng JW, Li Y, Xing WQ, et al. Laparoscopic Heller myotomy is not superior to pneumatic dilation in the management of primary achalasia: conclusions of a systematic review and meta-analysis of randomized controlled trials. Medicine . 2017;96(7):e5525.
  • Baniya R, Upadhaya S, Khan J, et al. Laparoscopic esophageal myotomy versus pneumatic dilation in the treatment of idiopathic achalasia: a meta-analysis of randomized controlled trials. Clin Exp Gastroenterol. 2017;10:241–248.
  • Illés A, Farkas N, Hegyi P, et al. Is Heller myotomy better than balloon dilation? A meta-analysis. J Gastrointestin Liver Dis. 2017;26(2):121–127.
  • Zaninotto G, Bennett C, Boeckxstaens G, et al. The 2018 ISDE achalasia guidelines. Dis Esophagus. 2018;31(9):doy071.
  • Costantini M, Salvador R, Capovilla G, et al. A thousand and one laparoscopic Heller myotomies for esophageal achalasia: a 25-year experience at a single tertiary center. J Gastrointest Surg. 2019;23(1):23–35.
  • von Renteln D, Inoue H, Minami H, et al. Peroral endoscopic myotomy for the treatment of achalasia: a prospective single center study. Am J Gastroenterol. 2012;107(3):411–417.
  • Ponds FA, Fockens P, Lei A, et al. Effect of peroral endoscopic myotomy vs pneumatic dilation on symptom severity and treatment outcomes among Treatment-Naive patients with achalasia: a randomized clinical trial. JAMA. 2019;322(2):134–144.
  • Felix VN. Results of pneumatic dilation in treating achalasia: predictive factors. Ann N Y Acad Sci. 2018;1434(1):124–131.
  • Sanaka MR, Hayat U, Thota PN, et al. Efficacy of peroral endoscopic myotomy vs other achalasia treatments in improving esophageal function. WJG. 2016;22(20):4918–4925.
  • Meng F, Li P, Wang Y, et al. Peroral endoscopic myotomy compared with pneumatic dilation for newly diagnosed achalasia. Surg Endosc. 2017;31(11):4665–4672.
  • Miller HJ, Neupane R, Fayezizadeh M, et al. POEM is a cost-effective procedure: cost-utility analysis of endoscopic and surgical treatment options in the management of achalasia. Surg Endosc. 2017;31(4):1636–1642.
  • Ehlers AP, Oelschlager BK, Pellegrini CA, et al. Achalasia treatment, outcomes, utilization, and costs: a population-based study from the United States. J Am Coll Surg. 2017;225(3):380–386.
  • Moonen A, Busch O, Costantini M, et al. Economic evaluation of the randomized European achalasia trial comparing pneumodilation with laparoscopic Heller myotomy. Neurogastroenterol Motil. 2017;29(11):e13115.
  • Schnurre L, Murray FR, Schindler V, et al. Short-term outcome after singular hydraulic EsoFLIP dilation in patients with achalasia: a feasibility study. Neurogastroenterol Motil. 2020;32(9):e13864.
  • Chuah SK, Hu TH, Wu KL, et al. Endoscope-guided pneumatic dilatation of esophageal achalasia without fluoroscopy is another safe and effective treatment option: a report of Taiwan. Surg Laparosc Endosc Percutan Tech. 2008;18(1):8–12.
  • Tanaka Y, Iwakiri K, Kawami N, et al. Predictors of a better outcome of pneumatic dilatation in patients with primary achalasia. J Gastroenterol. 2010;45(2):153–158.
  • Ghoshal UC, Chaudhuri S, Pal BB, et al. Randomized controlled trial of intrasphincteric botulinum toxin and injection versus balloon dilatation in treatment of achalasia cardia. Dis Esophagus. 2001;14(3–4):227–231.
  • Maris T, Kapetanos D, Ilias A, et al. Mid term results of pneumatic balloon dilatation in patients with achalasia. Ann Gastroenterol. 2010;23:61–63.
  • Dobrucali A, Erzin Y, Tuncer M, et al. Long-term results of graded pneumatic dilatation under endoscopic guidance in patients with primary esophageal achalasia. World J Gastroenterol. 2004;10(22):3322–3327.
  • Allescher HD, Storr M, Seige M, et al. Treatment of achalasia: botulinum toxin injection vs. pneumatic balloon dilation. A prospective study with long-term follow-up. Endoscopy. 2001;33(12):1007–1017.
  • Mikaeli J, Bishehsari F, Montazeri G, et al. Pneumatic balloon dilatation in achalasia: a prospective comparison of safety and efficacy with different balloon diameters. Aliment Pharmacol Ther. 2004;20(4):431–436.
  • Weusten BLAM, Barret M, Bredenoord AJ, et al. Endoscopic management of gastrointestinal motility disorders – Part 1: European Society of Gastrointestinal Endoscopy (ESGE) guideline. Endoscopy. 2020;52(6):498–515.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.